Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Forty Seven hired Dr. Mark McCamish as chief executive officer and president. Most recently, he was global head of biopharmaceutical development at Sandoz, a unit of Novartis, and had previously worked at Abbott Laboratories, Amgen, and PDL Biopharma.